Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-24-027364

Director acquired 2,181 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Holder Michael Director 2024-11-18 Option exercise +2,181 3,635 D
Derivatives
Holder Michael Director 2024-11-18 Option exercise · Restricted Stock Units −2,181 22,543 D
Loading xslF345X05/form4-11202024_111103.xml…